REMEDI Inc. (KOSDAQ:387690)

Revenue by Segment

Financials in millions KRW. Fiscal year is January - December.

Fiscal Year	FY 2025	FY 2024	FY 2023
Period Ending	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023
X-Ray Equipment	14.63B	13.44B	6.92B
X-Ray Equipment Growth	8.83%	94.30%	-
Total	14.63B	13.44B	6.92B
Total Growth	8.83%	94.30%	-

Revenue by Geography

Financials in millions KRW. Fiscal year is January - December.

Fiscal Year	FY 2025	FY 2024	FY 2023
Period Ending	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023
South Korea	2.45B	2.40B	1.75B
South Korea Growth	1.87%	37.28%	-
Overseas	12.18B	11.04B	5.17B
Overseas Growth	10.35%	113.63%	-
Total	14.63B	13.44B	6.92B
Total Growth	8.83%	94.30%	-

Data Source: S&P Global Market Intelligence Last updated: Mar 31, 2026

Financial data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Jul 22, 2026

Data Sources Report a data error